Lite Strategy, Inc. (LITS) Insider Trading Disclosures
Lite Strategy, Inc. (LITS) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: LITS
CIK: 1262104
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 06/30
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 6/30/2024 12:00:00 AM
Lead Engagement PartnerKC Freer
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| EFFECT | 2026-10-06 | — | EFFECT Filing | 9999999995-26-003162 | View SEC Doc Filr Page |
| S-8 | 2026-09-28 | — | S-8 | 0001193125-26-405431 | View SEC Doc Filr Page |
| S-3 | 2026-09-28 | — | S-3 | 0001193125-26-405423 | View SEC Doc Filr Page |
| 10-K | 2026-09-28 | 2026-06-30 | 10-K | 0001193125-26-405328 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-03 | — | SCHEDULE 13G/A Filing | 0001079973-26-000999 | View SEC Doc Filr Page |
| 8-K | 2026-07-30 | 2026-07-30 | 8-K | 0001193125-26-325026 | View SEC Doc Filr Page |
| 8-K | 2026-07-24 | 2026-07-24 | 8-K | 0001193125-26-316284 | View SEC Doc Filr Page |
| 4 | 2026-06-25 | 2026-06-24 | 4 | 0001193125-26-282864 | View SEC Doc Filr Page |
| 8-K | 2026-05-13 | 2026-05-13 | 8-K | 0001193125-26-220697 | View SEC Doc Filr Page |
| 10-Q | 2026-05-13 | 2026-03-31 | 10-Q | 0001193125-26-220687 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-02-17 | — | SCHEDULE 13G/A Filing | 0001104659-26-016538 | View SEC Doc Filr Page |
| 8-K | 2026-02-17 | 2026-02-17 | 8-K | 0001193125-26-053243 | View SEC Doc Filr Page |
| 10-Q | 2026-02-17 | 2025-12-31 | 10-Q | 0001193125-26-053215 | View SEC Doc Filr Page |
| 4 | 2026-02-12 | 2026-02-12 | 4 | 0001193125-26-049089 | View SEC Doc Filr Page |
| 8-K | 2026-02-12 | 2026-02-12 | 8-K | 0001193125-26-049005 | View SEC Doc Filr Page |
| DEFA14A | 2026-01-27 | — | DEFA14A Filing | 0000929638-26-000268 | View SEC Doc Filr Page |
| ARS | 2025-12-30 | 2025-06-30 | ARS | 0001193125-25-337093 | View SEC Doc Filr Page |
| DEFA14A | 2025-12-30 | — | DEFA14A | 0001193125-25-337076 | View SEC Doc Filr Page |
| DEF 14A | 2025-12-30 | 2025-12-30 | DEF 14A | 0001193125-25-337041 | View SEC Doc Filr Page |
| 8-K | 2025-12-30 | 2025-12-23 | 8-K | 0001193125-25-335761 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2025-12-22 | — | SCHEDULE 13G/A Filing | 0001079973-25-001892 | View SEC Doc Filr Page |
| 4 | 2025-12-22 | 2025-12-18 | 4 Filing | 0001079973-25-001891 | View SEC Doc Filr Page |
| 4 | 2025-12-22 | 2025-12-19 | 4 | 0001193125-25-328666 | View SEC Doc Filr Page |
| 8-K | 2025-12-05 | 2025-12-02 | 8-K | 0001193125-25-309593 | View SEC Doc Filr Page |
| EFFECT | 2025-11-25 | — | EFFECT Filing | 9999999995-25-003383 | View SEC Doc Filr Page |